Evidence map›Paper›PMID 30042307›Full record

ReviewVaccines2018

Why Is Eradicating Typhoid Fever So Challenging: Implications for Vaccine and Therapeutic Design.

Yi-An Yang, Alexander Chong, Jeongmin Song

Abstract readReview
In one paragraph

Review in Vaccines, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. HeterogeneousJournal of medical microbiology · 2025
    Article
  6. Review
  7. Exploring the Antimicrobial Resistance Profile ofAntibiotics (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Bacterial AB toxins and host-microbe interactions.Advances in microbial physiology · 2022
    Review
  17. Article
  18. Investigating the Efficiency of Recombinant FliC-LoadedIranian journal of public health · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yi-An YangDepartment of Microbiology and Immunology, Cornell University College of Veterinary Medicine, Ithaca, NY 14853, USA. yy394@cornell.edu.
Alexander ChongDepartment of Microbiology and Immunology, Cornell University College of Veterinary Medicine, Ithaca, NY 14853, USA. ac936@cornell.edu.
Jeongmin SongDepartment of Microbiology and Immunology, Cornell University College of Veterinary Medicine, Ithaca, NY 14853, USA. jeongmin.song@cornell.edu.ORCID 0000-0002-6777-3505

Funding

Salmonella Typhi: Enhancement of Endemic Potential through its Unique Virulence FactorsR01AI141514 · NIAID · CORNELL UNIVERSITY · PI SONG, JEONGMIN · 2019 to 2023
$3.2M
Cracking Salmonella Typhis Secret Code: Understanding Pathogenic Mechanisms of Salmonella Typhi ToxinR01AI137345 · NIAID · CORNELL UNIVERSITY · PI SONG, JEONGMIN · 2018 to 2022
$2.7M
Typhoid Vaccines Targeting Both Salmonella Typhi and Its Secreted Virulence FactorR01AI139625 · NIAID · CORNELL UNIVERSITY · PI SONG, JEONGMIN · 2018 to 2022
$2.0M
Neutralizing Antibodies to Typhoid ToxinR03AI135767 · NIAID · CORNELL UNIVERSITY · PI MANTIS, NICHOLAS J., SONG, JEONGMIN · 2018 to 2019
$172k
NIAID NIH HHS R01 AI137345NIAID NIH HHS R01 AI139625NIAID NIH HHS R01 AI141514NIAID NIH HHS R03 AI135767
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic infectionshealthy carriersSalmonella Typhityphoidal Salmonellaetyphoid fevervaccinesvirulence

Identifiers

PMID30042307
PMCPMC6160957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.